MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2022 International Congress

    Importance of lifestyle advice for participants in studies of early Parkinson’s disease

    F. Fuchs, I. Tödt, A. Rogge, J. Naumann, D. Berg, E. Schäffer (Kiel, Germany)

    Objective: Estimating the ethical acceptability of early Parkinson’s Disease (PD) research among healthy individuals participating in a PD screening study in terms of risk disclosure…
  • 2022 International Congress

    Second Project: The feasibility and efficacy of virtual visits compared to in-person visits for management of Parkinson’s disease. A pilot, international, longitudinal, multicenter trial (NCT04695353).

    A. García-Bustillo, O. Ojo, N. Okubadejo, JH. Ahn, J. Youn, E. Eldayem, A. Shalash, A. Cardozo, Z. Aldaajani, J. Bajwa, M. Spindler, M. Shackleford, Z. Mari, E. Cubo (Burgos, Spain)

    Objective: To investigate the feasibility and efficacy of virtual visits for Parkinson's Disease (PD) compared to in-person visits. Background: Considering the limited access to specialists…
  • 2022 International Congress

    Oscillatory activity of pause-burst STN neurons shows an association with motor symptoms of Parkinson’s disease

    E. Belova, V. Filyushkina, I. Dzhalagoniia, A. Gamaleya, A. Tomskiy, A. Sedov (Moscow, Russian Federation)

    Objective: Here we aimed to investigate heterogeneity in the neuronal activity within the subthalamic nucleus (STN) to search the association between oscillatory activity and motor…
  • 2022 International Congress

    Assessment of microstructural changes associated with levodopa-induced dyskinesia in hemiparkinsonian rodents

    M. Bergamino, A. Fuentes, D. Marmion, I. Sandoval, C. Bishop, F. Manfredsson, A. Stokes (Phoenix, USA)

    Objective: To assess white matter (WM) microstructural integrity changes in pre-clinical models of Parkinson’s disease (PD) with levodopa-induced dyskinesia (LID). Background: PD is a neurodegenerative…
  • 2022 International Congress

    Investigating the use of DAT-SPECT as an enrichment biomarker to determine eligibility for the phase 2 clinical trial PASADENA

    T. Kustermann, S. Holiga, S. Zanigni, H. Svoboda, T. Nikolcheva, G. Pagano, K. Taylor (Basel, Switzerland)

    Objective: Evaluate dopaminergic imaging DAT-SPECT as an enrichment strategy to avoid inclusion of participants with scans without evidence of dopaminergic deficit (SWEDD) in a Phase…
  • 2022 International Congress

    Long-term follow-up of subthalamic nucleus deep brain stimulation for Parkinson’s disease: survival and disability milestones

    R. Barbosa, L. Correia-Guedes, M. Cattoni, P. Pita-Lobo, A. Castro-Caldas, M. Fabbri, P. Bastos, H. Carvalho, L. Albuquerque, S. Reimão, A. Gonçalves Ferreira, J. Ferreirajos, M. Rosa, M. Coelho (Lisbon, Portugal)

    Objective: To characterize retrospectively the long-term survival of 109 PD patients after 8 years of STN-DBS and to identify the incidence of the milestones of…
  • 2022 International Congress

    Cortical beta activity in doorway-provoked motor blocks in Parkinson’s disease

    S. Tran, J. Baarbe, R. Chen (Toronto, Canada)

    Objective: To investigate cortical activity of doorway-provoked motor blocks (MB) during pedalling in Parkinson’s disease (PD). Background: Freezing of gait (FOG) is common in PD…
  • 2022 International Congress

    Motor-Related and Cognition-Related Safety of Pimavanserin in Patients with Parkinson’s Disease Psychosis (PDP)

    V. Abler, C. Ballard, A. Berrio, B. Coate, C. Brain, A. Espay (San Diego, USA)

    Objective: Evaluate motor- and cognition-related safety in pimavanserin-treated patients with PDP. Background: Pimavanserin, a selective 5-HT2A inverse agonist/antagonist, is the only US FDA-approved treatment for…
  • 2022 International Congress

    Chronotype and Cognition in Veterans with Parkinson’s Disease

    A. Sarwar (Houston, USA)

    Objective: To determine if chronotype impacts the expression of dementia and/or depression in Veterans with Parkinson's disease (PD). Background: Chronotype reflects the periodicity of biological…
  • 2022 International Congress

    Use of virtual reality devices for the monitoring of Parkinson’s disease

    S. Hirczy, M. Salinas (Dallas, USA)

    Objective: To determine whether mass market virtual reality (VR) devices can be used to detect the motor manifestations of Parkinson’s disease and their response to…
  • « Previous Page
  • 1
  • …
  • 193
  • 194
  • 195
  • 196
  • 197
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley